CN105148077A - 一种具有降血糖功效的养生粥 - Google Patents
一种具有降血糖功效的养生粥 Download PDFInfo
- Publication number
- CN105148077A CN105148077A CN201510638168.XA CN201510638168A CN105148077A CN 105148077 A CN105148077 A CN 105148077A CN 201510638168 A CN201510638168 A CN 201510638168A CN 105148077 A CN105148077 A CN 105148077A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- preserving porridge
- health
- gained
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000008280 blood Substances 0.000 title claims abstract description 59
- 210000004369 blood Anatomy 0.000 title claims abstract description 59
- 235000021395 porridge Nutrition 0.000 title claims abstract description 44
- 235000000346 sugar Nutrition 0.000 title claims abstract description 32
- 230000036541 health Effects 0.000 title abstract description 6
- 230000003247 decreasing effect Effects 0.000 title abstract 3
- 230000000694 effects Effects 0.000 claims abstract description 39
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 31
- 229930006000 Sucrose Natural products 0.000 claims abstract description 30
- 240000008042 Zea mays Species 0.000 claims abstract description 9
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 9
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 9
- 235000005822 corn Nutrition 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 43
- 241000628997 Flos Species 0.000 claims description 28
- 210000000582 semen Anatomy 0.000 claims description 27
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 18
- 238000002360 preparation method Methods 0.000 claims description 17
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 15
- 241000212324 Oenanthe <angiosperm> Species 0.000 claims description 15
- 239000000706 filtrate Substances 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 14
- 239000002994 raw material Substances 0.000 claims description 11
- 238000009835 boiling Methods 0.000 claims description 8
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 8
- 240000007594 Oryza sativa Species 0.000 claims description 7
- 235000007164 Oryza sativa Nutrition 0.000 claims description 7
- 235000013339 cereals Nutrition 0.000 claims description 7
- 230000035613 defoliation Effects 0.000 claims description 7
- 229910052742 iron Inorganic materials 0.000 claims description 7
- 235000009566 rice Nutrition 0.000 claims description 7
- 238000010257 thawing Methods 0.000 claims description 7
- 239000003814 drug Substances 0.000 abstract description 27
- 201000001421 hyperglycemia Diseases 0.000 abstract description 16
- 235000013305 food Nutrition 0.000 abstract description 10
- 208000002193 Pain Diseases 0.000 abstract description 9
- 230000036407 pain Effects 0.000 abstract description 9
- 240000007087 Apium graveolens Species 0.000 abstract description 3
- 206010010904 Convulsion Diseases 0.000 abstract description 3
- 230000036461 convulsion Effects 0.000 abstract description 3
- 210000005036 nerve Anatomy 0.000 abstract description 3
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 abstract description 2
- 235000010591 Appio Nutrition 0.000 abstract description 2
- 241000721690 Lythrum salicaria Species 0.000 abstract description 2
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 240000005250 Chrysanthemum indicum Species 0.000 abstract 1
- 241000931705 Cicada Species 0.000 abstract 1
- 241000037740 Coptis chinensis Species 0.000 abstract 1
- 241001289529 Fallopia multiflora Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 28
- 239000008103 glucose Substances 0.000 description 28
- 208000024891 symptom Diseases 0.000 description 13
- 235000001727 glucose Nutrition 0.000 description 11
- 230000002218 hypoglycaemic effect Effects 0.000 description 11
- 208000004880 Polyuria Diseases 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 206010018473 Glycosuria Diseases 0.000 description 5
- 206010047700 Vomiting Diseases 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 206010036067 polydipsia Diseases 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 230000008673 vomiting Effects 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 230000003204 osmotic effect Effects 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 241000819999 Nymphes Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 206010040872 skin infection Diseases 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Chinese gallotannin Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010020710 Hyperphagia Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000003642 hunger Nutrition 0.000 description 2
- 230000003345 hyperglycaemic effect Effects 0.000 description 2
- 230000002267 hypothalamic effect Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 208000022530 polyphagia Diseases 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 210000005239 tubule Anatomy 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 1
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 235000002764 Apium graveolens Nutrition 0.000 description 1
- JXRNMQDTJAQLAQ-UTZXOHNXSA-N Aplotaxene Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCC=C JXRNMQDTJAQLAQ-UTZXOHNXSA-N 0.000 description 1
- ZFSOYHNWYLNZIP-UHFFFAOYSA-N Aplotaxene Natural products CCC=CCC=CC=CCCCCCCC=C ZFSOYHNWYLNZIP-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 241001131796 Botaurus stellaris Species 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 244000019459 Cynara cardunculus Species 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- PLAPMLGJVGLZOV-UHFFFAOYSA-N Epi-orientin Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=CC2=O PLAPMLGJVGLZOV-UHFFFAOYSA-N 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000000857 Hepatic Insufficiency Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- JXRNMQDTJAQLAQ-UHFFFAOYSA-N Heptadecatetraen Natural products CCC=CCC=CCC=CCCCCCC=C JXRNMQDTJAQLAQ-UHFFFAOYSA-N 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- BAHUBXAYVOCLNA-UHFFFAOYSA-N Isoangelol Natural products O1C(=O)C=CC2=C1C=C(OC)C(C(OC(=O)C(C)=CC)C(O)C(C)(C)O)=C2 BAHUBXAYVOCLNA-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 244000303199 Lamium album Species 0.000 description 1
- 235000009199 Lamium album Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- PTNJRKBWIYNFSY-UHFFFAOYSA-N Lirinin-O-methyl-ether Natural products COc1ccc-2c(CC3N(C)CCc4cc(OC)c(OC)c-2c34)c1 PTNJRKBWIYNFSY-UHFFFAOYSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 241000721692 Lythrum Species 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- RBVAFYCFAFADAG-UHFFFAOYSA-N Orientin Natural products OCC1OC(C(O)c2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)c(O)c4)C(O)C1O RBVAFYCFAFADAG-UHFFFAOYSA-N 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- DUXQKCCELUKXOE-UHFFFAOYSA-N Pectolinarigenin-Biosid Natural products C1=CC(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C(OC)=C2OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(C)O2)O)O1 DUXQKCCELUKXOE-UHFFFAOYSA-N 0.000 description 1
- SEXCCMQJDXQBOE-UHFFFAOYSA-N Pectolinarin Natural products C1=CC(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C(OC)=C2OC1C(O)C(O)C(OC2C(C(O)C(O)C(C)O2)O)C(CO)O1 SEXCCMQJDXQBOE-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 1
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- LQSNPVIQIPKOGP-UHFFFAOYSA-N UNPD159785 Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=CC2=O LQSNPVIQIPKOGP-UHFFFAOYSA-N 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 229930183733 angelol Natural products 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001716 anti-fugal effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 239000001387 apium graveolens Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000003130 cardiopathic effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229920002824 gallotannin Polymers 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 150000002304 glucoses Chemical class 0.000 description 1
- 230000000848 glutamatergic effect Effects 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 230000004140 ketosis Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical compound COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 description 1
- 229960002237 metoprolol Drugs 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- PEFNSGRTCBGNAN-UHFFFAOYSA-N nephrocizin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 PEFNSGRTCBGNAN-UHFFFAOYSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- PLAPMLGJVGLZOV-VPRICQMDSA-N orientin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=CC2=O PLAPMLGJVGLZOV-VPRICQMDSA-N 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- DUXQKCCELUKXOE-CBBZIXHGSA-N pectolinarin Chemical compound C1=CC(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C(OC)=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 DUXQKCCELUKXOE-CBBZIXHGSA-N 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- IENZQIKPVFGBNW-UHFFFAOYSA-N prazosin Chemical compound N=1C(N)=C2C=C(OC)C(OC)=CC2=NC=1N(CC1)CCN1C(=O)C1=CC=CO1 IENZQIKPVFGBNW-UHFFFAOYSA-N 0.000 description 1
- 229960001289 prazosin Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 239000008517 radix Trichosanthis Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 1
- 229960003147 reserpine Drugs 0.000 description 1
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000004577 thatch Substances 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/143—Cereal granules or flakes to be cooked and eaten hot, e.g. oatmeal; Reformed rice products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Insects & Arthropods (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种具有降血糖功效的养生粥,取下述重量配比的主要原料制备而成:茯苓1-5份,千屈菜1-3份,降香2-6份,芹菜30-40份,玉米80-180份,蝉蜕4-10份,何首乌2-6份,黄连5-8份,丹参6-10份,菊花4-8份,独活8-12份,大蓟6-10份,白糖10-20份。本发明中药组合物符合中医治疗高血糖的原理。选用的药材有降低血糖的功效,并且药材与食物搭配,且能舒缓心郁气结、止痛、安神定惊,对高血糖患者有极好的治疗作用,是目前是治疗高血糖较为理想的食物。
Description
分案申请,原申请号2014103252004,申请日2014.07.09,名称一种具有降血糖功效的养生粥及其制作方法。
技术领域
本发明涉及中医中药领域,尤其是涉及一种具有降血糖功效的养生粥及其制作方法。
背景技术
当空腹(8小时内无糖及任何含糖食物摄入)血糖高于正常范围,称为高血糖,空腹血糖正常值4.0-6.1mmol/L,餐后两小时血糖高于正常范围7.8mmol/L,也可以称为高血糖,高血糖不是一种疾病的诊断,只是一种血糖监测结果的判定,血糖监测是一时性的结果,高血糖不完全等于糖尿病。
血糖升高,尿糖增多,可引发渗透性利尿,从而引起多尿的症状;血糖升高、大量水分丢失,血渗透压也会相应升高,高血渗可刺激下丘脑的口渴中枢,从而引起口渴、多饮的症状;由于胰岛素相对或绝对的缺乏,导致体内葡萄糖不能被利用,蛋白质和脂肪消耗增多,从而引起乏力、体重减轻;为了补偿损失的糖分,维持机体活动,需要多进食;这就形成了典型的“三多一少”症状。糖尿病病人的多饮、多尿症状与病情的严重程度呈正比。另外,值得注意的是,患者吃得越多,血糖就越高,尿中失糖也越多,饥饿感也就越厉害,最终导致了恶性循环。因此,在这种情况下,以少吃为好,但不能少于每日150克主食。但如果糖尿病未缓解,病人的食欲突然降低,此时应注意是否合并感染、酮症及其他并发症。(1)尿多,皮肤乾燥,脱水(2)极度口渴(3)恶心,呕吐,腹部不适(4)厌食,体重减轻,虚弱无力(5)心跳快速,呼吸缓而深(6)血糖测试值升高(7)尿糖测试呈阳性反应。
“三多一少”是糖尿病最常见的临床表现,即为多饮、多食、多尿和体重减轻。然而,我们发现目前临床上有相当一部分糖尿病病人,因为没有典型的“三多一少”症状而延误了病情。
有些2型糖尿病病人没有明显的“三多一少”症状,这是由于病人的肾糖阈增高所致。正常情况下葡萄糖在肾脏内全部被重吸收,尿中无糖排出;若血糖轻度升高,肾小管的重吸收值会相应增加;但当血糖升高到一定水平,超出了肾小管的最大重吸收范围,则部分葡萄糖将从尿中排出,从而形成糖尿。这个血糖临界值即为肾糖阈,正常值为8.8~9.9毫摩尔/升(mmol/L)。肾脏病及其他一些泌尿系统疾病都会对其产生不同程度的影响,而且多数老龄患者的肾糖阈也会相应增高。肾糖阈增高后,病人即使血糖很高也不会有糖尿。没有糖尿,就不会引发渗透性利尿,因此可没有多尿症状;没有丢失大量水分,血浆渗透压就变化较轻,对下丘脑中枢的刺激也相应减轻,因此可没有口渴、多饮症状;没有糖尿,就不会损失大量糖分,因此可没有明显的饥饿感,多食症状减轻;没有糖尿,机体的营养成分丢失减少,因此体重减轻的程度也可相应减轻。由此,这些糖尿病病人可以最终不出现“三多一少”的症状。
在现有的降血糖的药物中,申请公布号CN102284039A(申请号201110262940.4)的专利公开了一种降血糖中药制剂,其特征是,其有效成分由下述重量份的原料药制成:葛根8、知母6、玉竹8、五味子10、山药10、乌梅8、三七6、槐角8、白茅根5、山楂12、决明子10、桃仁12、郁金8、灵芝10、蜂蜜15。授权公告号CN102940782B(申请号201210524373.X)的专利公开了一种降血糖的中药组合物,其特征在于,由如下重量份的中药材制成汤剂:黑芝麻10份、龙眼肉10份、桑葚10份、生地黄5份、麦冬5份、天花粉5份、黄芪5份、枸杞子5份、葛根5份、红参5份、茯苓5份、牡丹皮5份、五味子5份、酸枣仁3份、柏子仁3份、合欢皮3份、石斛3份、枸杞子3份、女贞子3份、百合3份、川楝子3份。
由此看来:中药在降低血糖方面具有非常重要的作用,但是现有技术中,都是用纯中药来降低血糖,还没有一种用来降低血糖的养生粥。
发明内容
针对现有的治疗现状,本发明的目的之一在于提供一种治疗高血糖性心脏病的中药组合物,具有无痛苦、易操作、疗效显著、无副作用的特点,并且它采用地方上较为常见的中药材作为原料,成本低廉。
本发明的另一目的就是提供上述中药组合物的制备方法。
本发明的上述目的是通过以下技术方案来实现的:
一种具有降血糖功效的养生粥,取下述重量配比的主要原料制备而成:茯苓1-5份,千屈菜1-3份,降香2-6份,芹菜30-40份,玉米80-180份,蝉蜕4-10份,何首乌2-6份,黄连5-8份,丹参6-10份,菊花4-8份,独活8-12份,大蓟6-10份,白糖10-20份。
一种具有降血糖功效的养生粥,优选的方案在于:取下述重量配比的主要原料制备而成:茯苓2-4份,千屈菜1.5-2.5份,降香3-5份,芹菜33-38份,玉米110-150份,蝉蜕6-8份,何首乌3-5份,黄连6-7份,丹参7-9份,菊花5-7份,独活9-11份,大蓟7-9份,白糖13-18份。
一种具有降血糖功效的养生粥,更佳优选的方案在于:取下述重量配比的主要原料制备而成:茯苓3份,千屈菜2份,降香4份,芹菜35份,玉米130份,蝉蜕7份,何首乌4份,黄连6.5份,丹参8份,菊花6份,独活10份,大蓟8份,白糖15份。
根据前面所述具有降血糖功效的养生粥的制备方法,优选的方案在于:步骤如下:
(1)将芹菜去叶洗净,切成指甲盖大小的块,放入榨汁机中加水,榨1-3分钟后,取出芹菜汁待用;
(2)将菊花和蝉蜕置于80-100℃的热水中浸泡,浸泡至水温为30-40℃时,过滤,得滤液,滤液与步骤(1)所得芹菜汁混合备用;
(3)将玉米研磨成大米粒大小的块,过60-100目筛;
(4)将茯苓、千屈菜、降香、何首乌、黄连、丹参、独活和大蓟混合,加入到步骤(2)所得混合液中浸泡2-4小时(优选浸泡3小时),武火煎开,转文火煎30-40分钟,滤出药液备用;
(5)将步骤(3)所得玉米块与步骤(4)所得药液混合,置于铁锅内,小火熬制1-3小时后加入白糖,充分搅拌至白糖融化后武火煎开即得养生粥。
根据前面所述的制备方法,优选的方案在于:步骤(1)水的用量是芹菜质量的1-5倍(优选的,水的用量是芹菜质量的2-4倍;更加优选的,水的用量是芹菜质量的3倍)。
根据前面所述的制备方法,优选的方案在于:步骤(2)水的用量是菊花和蝉蜕总用量的2-6倍(优选的,水的用量是菊花和蝉蜕总用量的3-5倍,更加优选的,水的用量是菊花和蝉蜕总用量的4倍)。
根据前面所述的制备方法,优选的方案在于:步骤(2)将菊花和蝉蜕置于85-95℃的热水中浸泡(优选置于90℃的热水中浸泡)。
根据前面所述的制备方法,优选的方案在于:步骤(2)浸泡至水温为33-38℃时过滤(优选浸泡至水温为35℃时过滤)。
根据前面所述的制备方法,优选的方案在于:步骤(3)玉米块过70-90目筛(优选过80目筛)。
根据前面所述的制备方法,优选的方案在于:步骤(5)小火熬制1.5-2.5小时后加入白糖(小火熬制2小时后加入白糖)。
使用方法:为使本发明达到最佳效果,制好的养生粥,每次取20-40g,与早晚饭同食。
各原料药的药理功效分别为:
茯苓:味甘、淡,性平。有利水渗湿,健脾宁心的功效,用于水肿尿少,心神不安,脾虚食少。
千屈菜:又名对叶莲、蜈蚣草、对牙草,为千屈菜科千屈菜属植物千屈菜的全草。药性:味苦,性寒。成分:全草含千屈菜苷,胆碱,没食子鞣质,荭草素,绿原酸等。根据现代药理研究发现,该药具有降血糖、抗菌、清热解毒、收敛止血的功效,用于高血糖,吐血,衄血,泄泻,疮疡溃烂等。
降香:味辛,性温。有行气活血,止痛,止血的功效,用于脘腹疼痛,肝郁胁痛,胸痹刺痛。
芹菜:芹菜,属伞形科植物。有水芹、旱芹两种,功能相近,药用以旱芹为佳。旱芹香气较浓,又名“香芹”,亦称"药芹"。富含蛋白质、碳水化合物、胡萝卜素、B族维生素、钙、磷、铁、钠等,同时,具有有平肝清热,祛风利湿,除烦消肿,凉血止血,解毒宣肺,健胃利血、清肠利便、润肺止咳、降低血压、健脑镇静的功效。常吃芹菜,尤其是吃芹菜叶,对预防高血糖、动脉硬化等都十分有益,并有辅助治疗作用。
玉米:玉米营养丰富:含有碳水化合物:74.8克,蛋白质:29克,脂肪:16.6克,膳食纤维6.9克。可以说玉米是当之无愧的第一黄金主食”,营养专家称,玉米所含的“全能营养”适合各个年龄段的人群食用,其丰富的谷氨酸能促进大脑发育,是儿童最好的“益智食物”;所含维生素B族能调节神经,是适合白领的“减压食品”;富含的亚油酸、钙质,能帮助调脂、降压,高纤维含量则使玉米成为很好的“刮肠食物”,能预防中年发福;此外,玉米中富含的谷胱甘肽是最有效的抗癌成分,其所含丰富的维生素E也能帮助抗衰老,软化血管。具有利尿、降压、利胆、降血糖的功效。
蝉蜕:蝉蜕老熟若虫变化为成虫时,羽化蜕除的外壳称蝉蜕,又称“蝉退”或“蝉皮”,其主要成分含甲壳素及蛋白质,味甘、咸、寒,入肺、肝经,是重要的辛凉解表中药。蝉蜕作为传统中药成分,具有抗菌、祛寒、镇惊、利尿的功能。鲜嫩的蝉蜕若虫和成虫,特别是若虫不仅营养丰富、味道鲜美,药用价值也特别高,为药膳上品。
何首乌:性味:苦、甘、涩.温。归经:归肝、心、肾经。功效:解毒,消脱,润肠通便。主治:用于瘰疬疮痈,风疹瘙痒,肠燥便秘;高血脂。
黄连:功效清热燥湿,泻火解毒。用于湿热痞满,呕吐吞酸,泻痢,黄疸,高热神昏,心火亢盛,心烦不寐,血热吐衄,目赤,牙痛,消渴,痈肿疔疮;外治湿疹,湿疮,耳道流脓。酒黄连善清上焦火热。用于目赤,口疮。姜黄连清胃和胃止呕。用于寒热互结,湿热中阻,痞满呕吐。萸黄连舒肝和胃止呕。用于肝胃不和,呕吐吞酸。药理作用:1、抗菌作用2、抗真菌作用3、抗病毒作用4、抗阿米巴作用5、抗炎、抗腹泻作用6.、对心血管作用7、解热作用8、降血糖作用9、降血脂作用10、抗氧化作用11、对血液系统的影响12、抗溃疡作用。
丹参:性味:苦,微寒。归经:归心、肝经。功效:祛瘀止痛,活血通经,清心除烦。
主治:用于月经不调,经闭痛经,癥瘕积聚,胸腹刺痛,热痹疼痛,疮疡肿痛,心烦不眠;肝脾肿大,心绞痛。
菊花:性味:甘、苦,微寒。归经:归肺、肝经。功效:散风清热,平肝明目。主治:用于风热感冒,头痛眩晕,目赤肿痛,眼目昏花。
独活:为伞形科当归属植物重齿当归的根。成分:含香豆素类化合物,挥发油,乙酸酯,当归醇,百里香酚。药理:对心血管系统有很重要的作用,有降压的作用,能促进血小板的聚集,具有良好的镇痛和抗炎作用。具有抗光敏的作用,对抵抗肿瘤有显著的疗效,对抗菌消炎也有很重要的作用。药性:苦,微温,辛。归肾、膀胱经。功能主治:祛风胜湿,散寒止痛。
大蓟:又名马蓟、野刺菜、茨芥,为菊科蓟属植物大蓟的地上部分或根。药性:味甘,性微凉。成分:新鲜叶含有柳穿鱼苷;根含挥发油成分单紫杉烯,香附子烯,丁香烯。根据现代药理研究发现,该药具有止血、降压、抗菌、行瘀消肿的功效,用于吐血,咯血,衄血,便血,尿血,疮疡肿痛,肾炎,湿疹等。
白糖是由甘蔗和甜菜榨出的糖蜜制成的精糖。白糖色白,干净,甜度高,白糖性平,味甘,润肺生津、补中益气、清热燥湿、化痰止咳,、解毒醒酒、降浊怡神;可用于治疗中虚脘痛、脾虚泄泻、肺燥咳嗽、口干燥渴以及脚气、疥疮、盐卤中毒、阴囊湿疹等病症。此外,白糖有抑菌防腐的作用。
本发明中药组合物符合中医治疗高血糖的原理。选用的药材有降血糖的功效,并且药材与食物搭配,且能舒缓心郁气结、止痛、安神定惊,对高血糖患者有极好的治疗作用,是目前是治疗高血糖较为理想的食物。
与现有技术相比,本发明的技术优势还体现在:
本发明与现有技术相比较,其技术效果体现在:
(1)制备方法简单,提取效率高,能耗及损耗小,成本低;
(2)增加了营养成分和药效成分,但没有改变各原料制备的养生粥的风味;
(3)长期服用本品对降低高血糖、治疗肝功能障碍有特殊疗效,还能美容养颜,补脾养心。
具体实施方式
下面结合实施例和实验例详细说明本发明的技术方案,但保护范围不被此限制。
实施例1:一种具有降血糖功效的养生粥,取下述重量配比的主要原料制备而成(每份取10g):茯苓1份,千屈菜1份,降香2份,芹菜30份,玉米80份,蝉蜕4份,何首乌2份,黄连5份,丹参6份,菊花4份,独活8份,大蓟6份,白糖10份。
具有降血糖功效的养生粥的制备方法,步骤如下:
(1)将芹菜去叶洗净,切成指甲盖大小的块,放入榨汁机中加水,水的用量是芹菜质量的1倍,榨1分钟后,取出芹菜汁待用;
(2)将菊花和蝉蜕置于80℃的热水中浸泡,热水的用量是菊花和蝉蜕总用量的2倍,浸泡至水温为30℃时,过滤,得滤液,滤液与步骤(1)所得芹菜汁混合备用;
(3)将玉米研磨成大米粒大小的块,过60目筛;
(4)将茯苓、千屈菜、降香、何首乌、黄连、丹参、独活和大蓟混合,加入到步骤(2)所得混合液中浸泡2小时,武火煎开,转文火煎30分钟,滤出药液备用;
(5)将步骤(3)所得玉米块与步骤(4)所得药液混合,置于铁锅内,小火熬制1小时后加入白糖,充分搅拌至白糖融化后武火煎开即得养生粥。
典型病例一:陈某某,男,51岁,某企业的职工,3年前出现口渴、多饮的症状,而且总是感觉全身无力,不愿意运动,上3楼还要休息休息才能上去,去医院检查患有糖尿病,血糖值11.5mmol/L,由于患者想保守治疗,所以医生建议服用本发明养生粥。
服用实施例1所得养生粥10天,去医院检查血糖值降低到9.3mmol/L,又继续服用本实施例1所得养生粥10天后,血糖值降低到8.1mmol/L以下,患者见效果显著就一直服用实施例1所得养生粥,身体状况一直很好,没有出现任何不适症状。
实施例2:一种具有降血糖功效的养生粥,取下述重量配比的主要原料制备而成(每份取15g):茯苓5份,千屈菜3份,降香6份,芹菜40份,玉米180份,蝉蜕10份,何首乌6份,黄连8份,丹参10份,菊花8份,独活12份,大蓟10份,白糖20份。
具有降血糖功效的养生粥的制备方法,步骤如下:
(1)将芹菜去叶洗净,切成指甲盖大小的块,放入榨汁机中加水,水的用量是芹菜质量的5倍,榨3分钟后,取出芹菜汁待用;
(2)将菊花和蝉蜕置于100℃的热水中浸泡,热水的用量是菊花和蝉蜕总用量的6倍,浸泡至水温为40℃时,过滤,得滤液,滤液与步骤(1)所得芹菜汁混合备用;
(3)将玉米研磨成大米粒大小的块,过100目筛;
(4)将茯苓、千屈菜、降香、何首乌、黄连、丹参、独活和大蓟混合,加入到步骤(2)所得混合液中浸泡4小时,武火煎开,转文火煎40分钟,滤出药液备用;
(5)将步骤(3)所得玉米块与步骤(4)所得药液混合,置于铁锅内,小火熬制3小时后加入白糖,充分搅拌至白糖融化后武火煎开即得养生粥。
实施例3:一种具有降血糖功效的养生粥,取下述重量配比的主要原料制备而成(每份取20g):茯苓2份,千屈菜1.5份,降香3份,芹菜33份,玉米110份,蝉蜕6份,何首乌3份,黄连6份,丹参7份,菊花5份,独活9份,大蓟7份,白糖13份。
具有降血糖功效的养生粥的制备方法,步骤如下:
(1)将芹菜去叶洗净,切成指甲盖大小的块,放入榨汁机中加水,水的用量是芹菜质量的2倍,榨1.5分钟后,取出芹菜汁待用;
(2)将菊花和蝉蜕置于85℃的热水中浸泡,热水的用量是菊花和蝉蜕总用量的3倍,浸泡至水温为33℃时,过滤,得滤液,滤液与步骤(1)所得芹菜汁混合备用;
(3)将玉米研磨成大米粒大小的块,过70目筛;
(4)将茯苓、千屈菜、降香、何首乌、黄连、丹参、独活和大蓟混合,加入到步骤(2)所得混合液中浸泡2.5小时,武火煎开,转文火煎33分钟,滤出药液备用;
(5)将步骤(3)所得玉米块与步骤(4)所得药液混合,置于铁锅内,小火熬制1.5小时后加入白糖,充分搅拌至白糖融化后武火煎开即得养生粥。
实施例4:一种具有降血糖功效的养生粥,取下述重量配比的主要原料制备而成(每份取25g):茯苓4份,千屈菜2.5份,降香5份,芹菜38份,玉米150份,蝉蜕8份,何首乌5份,黄连7份,丹参9份,菊花7份,独活11份,大蓟9份,白糖18份。
具有降血糖功效的养生粥的制备方法,步骤如下:
(1)将芹菜去叶洗净,切成指甲盖大小的块,放入榨汁机中加水,水的用量是芹菜质量的4倍,榨2.5分钟后,取出芹菜汁待用;
(2)将菊花和蝉蜕置于95℃的热水中浸泡,热水的用量是菊花和蝉蜕总用量的5倍,浸泡至水温为38℃时,过滤,得滤液,滤液与步骤(1)所得芹菜汁混合备用;
(3)将玉米研磨成大米粒大小的块,过90目筛;
(4)将茯苓、千屈菜、降香、何首乌、黄连、丹参、独活和大蓟混合,加入到步骤(2)所得混合液中浸泡3.5小时,武火煎开,转文火煎38分钟,滤出药液备用;
(5)将步骤(3)所得玉米块与步骤(4)所得药液混合,置于铁锅内,小火熬制2.5小时后加入白糖,充分搅拌至白糖融化后武火煎开即得养生粥。
典型病例二孙某,女,58岁,自从退休后,一直在家带孙子,前一段时间突然感觉头晕,体力不支,而且老是口渴,血糖高,血糖值为8.9mmol/L,去医院检查发现是血糖高。
服用实施例4所得养生粥15天,配合适量运动,血糖值降低到6.1mmol/L,继续服用实施例4所得养生粥10天后,血糖恢复正常,患者一直实施例4所得养生粥,血糖一直很稳定。
实施例5:一种具有降血糖功效的养生粥,取下述重量配比的主要原料制备而成(每份取30g):茯苓3份,千屈菜2份,降香4份,芹菜35份,玉米130份,蝉蜕7份,何首乌4份,黄连6.5份,丹参8份,菊花6份,独活10份,大蓟8份,白糖15份。
具有降血糖功效的养生粥的制备方法,步骤如下:
(1)将芹菜去叶洗净,切成指甲盖大小的块,放入榨汁机中加水,水的用量是芹菜质量的3倍,榨2分钟后,取出芹菜汁待用;
(2)将菊花和蝉蜕置于90℃的热水中浸泡,热水的用量是菊花和蝉蜕总用量的4倍,浸泡至水温为35℃时,过滤,得滤液,滤液与步骤(1)所得芹菜汁混合备用;
(3)将玉米研磨成大米粒大小的块,过80目筛;
(4)将茯苓、千屈菜、降香、何首乌、黄连、丹参、独活和大蓟混合,加入到步骤(2)所得混合液中浸泡3小时,武火煎开,转文火煎35分钟,滤出药液备用;
(5)将步骤(3)所得玉米块与步骤(4)所得药液混合,置于铁锅内,小火熬制2.5小时后加入白糖,充分搅拌至白糖融化后武火煎开即得养生粥。
实验例目的在于验证一下本发明养生粥对治疗高血糖是否具有疗效。从2012年1月到2014年1月,共150例高血糖患者,平均年龄为45岁。随机划分为给药组和对照组。
在实验之前的一周,记录病人的身体状况,每天查看一下患者身体症状,确保给药组和对照组情况基本一致。给药组每天食用本产品实施例5所得养生粥,对照组服用其他治疗高血糖的药物(美托洛尔、利舍平、哌唑嗪等常规治疗高血糖的药物)每天查看患者身体状况,做好记录。结果如下表1:
表1:
服用本发明养生粥在降血糖方面,效果显著,经临床试验证明有效率为96%,治愈率为92%,与单纯降血糖的西药相比,有效率高26%,治愈率高32%,且不需再服用其它降血糖的药物进行辅助治疗,减轻了患者身体和经济上的负担;与降血糖的中药相比,有效率高20%,治愈率高22%,且不仅能够降血糖,还能增强免疫力,因此,本发明养生粥是一种疗效全面的降血糖的食物。
Claims (2)
1.一种具有降血糖功效的养生粥,其特征是,取下述重量配比的主要原料制备而成:茯苓1份,千屈菜1份,降香2份,芹菜30份,玉米80份,蝉蜕4份,何首乌2份,黄连5份,丹参6份,菊花4份,独活8份,大蓟6份,白糖10份。
2.具有降血糖功效的养生粥的制备方法,其特征是,步骤如下:
(1)将芹菜去叶洗净,切成指甲盖大小的块,放入榨汁机中加水,水的用量是芹菜质量的1倍,榨1分钟后,取出芹菜汁待用;
(2)将菊花和蝉蜕置于80℃的热水中浸泡,热水的用量是菊花和蝉蜕总用量的2倍,浸泡至水温为30℃时,过滤,得滤液,滤液与步骤(1)所得芹菜汁混合备用;
(3)将玉米研磨成大米粒大小的块,过60目筛;
(4)将茯苓、千屈菜、降香、何首乌、黄连、丹参、独活和大蓟混合,加入到步骤(2)所得混合液中浸泡2小时,武火煎开,转文火煎30分钟,滤出药液备用;
(5)将步骤(3)所得玉米块与步骤(4)所得药液混合,置于铁锅内,小火熬制1小时后加入白糖,充分搅拌至白糖融化后武火煎开即得养生粥。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410325200.4A CN104082672B (zh) | 2014-07-09 | 2014-07-09 | 一种具有降血糖功效的养生粥及其制作方法 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410325200.4A Division CN104082672B (zh) | 2014-07-09 | 2014-07-09 | 一种具有降血糖功效的养生粥及其制作方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105148077A true CN105148077A (zh) | 2015-12-16 |
Family
ID=51630520
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410325200.4A Expired - Fee Related CN104082672B (zh) | 2014-07-09 | 2014-07-09 | 一种具有降血糖功效的养生粥及其制作方法 |
CN201510634500.5A Withdrawn CN105166656A (zh) | 2014-07-09 | 2014-07-09 | 具有降血糖功效养生粥的制法 |
CN201510638168.XA Withdrawn CN105148077A (zh) | 2014-07-09 | 2014-07-09 | 一种具有降血糖功效的养生粥 |
CN201510638207.6A Withdrawn CN105166661A (zh) | 2014-07-09 | 2014-07-09 | 具有降血糖功效的养生粥的制备方法 |
CN201510634498.1A Withdrawn CN105495284A (zh) | 2014-07-09 | 2014-07-09 | 一种具有降血糖功效养生粥的制作方法 |
CN201510638138.9A Withdrawn CN105148076A (zh) | 2014-07-09 | 2014-07-09 | 一种具有降血糖功效养生粥及其制作方法 |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410325200.4A Expired - Fee Related CN104082672B (zh) | 2014-07-09 | 2014-07-09 | 一种具有降血糖功效的养生粥及其制作方法 |
CN201510634500.5A Withdrawn CN105166656A (zh) | 2014-07-09 | 2014-07-09 | 具有降血糖功效养生粥的制法 |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510638207.6A Withdrawn CN105166661A (zh) | 2014-07-09 | 2014-07-09 | 具有降血糖功效的养生粥的制备方法 |
CN201510634498.1A Withdrawn CN105495284A (zh) | 2014-07-09 | 2014-07-09 | 一种具有降血糖功效养生粥的制作方法 |
CN201510638138.9A Withdrawn CN105148076A (zh) | 2014-07-09 | 2014-07-09 | 一种具有降血糖功效养生粥及其制作方法 |
Country Status (1)
Country | Link |
---|---|
CN (6) | CN104082672B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104351623A (zh) * | 2014-10-13 | 2015-02-18 | 毕红山 | 一种明目益精药膳粥 |
CN104491529A (zh) * | 2014-12-16 | 2015-04-08 | 济南方宇文化传媒有限公司 | 一种治疗ii型糖尿病的中药颗粒剂及其制备方法 |
CN104621258A (zh) * | 2015-01-15 | 2015-05-20 | 山东省农业科学院畜牧兽医研究所 | 具有降血糖功效的保健牛奶及其制备方法 |
CN104605269A (zh) * | 2015-03-04 | 2015-05-13 | 段英兰 | 利于糖尿病患者服用的保健粥及制备方法 |
CN106666350A (zh) * | 2016-11-03 | 2017-05-17 | 谌小丰 | 一种降血糖米粥 |
CN108651821A (zh) * | 2017-03-27 | 2018-10-16 | 朱凤玲 | 一种药膳粥 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1108483A (zh) * | 1994-03-12 | 1995-09-20 | 陈顺志 | 一种快餐药粥的生产方法 |
CN103055126B (zh) * | 2013-01-17 | 2014-06-18 | 张晓兰 | 一种治疗高血压性心脏病的中药组合物及其制备方法 |
-
2014
- 2014-07-09 CN CN201410325200.4A patent/CN104082672B/zh not_active Expired - Fee Related
- 2014-07-09 CN CN201510634500.5A patent/CN105166656A/zh not_active Withdrawn
- 2014-07-09 CN CN201510638168.XA patent/CN105148077A/zh not_active Withdrawn
- 2014-07-09 CN CN201510638207.6A patent/CN105166661A/zh not_active Withdrawn
- 2014-07-09 CN CN201510634498.1A patent/CN105495284A/zh not_active Withdrawn
- 2014-07-09 CN CN201510638138.9A patent/CN105148076A/zh not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CN105166656A (zh) | 2015-12-23 |
CN105495284A (zh) | 2016-04-20 |
CN105148076A (zh) | 2015-12-16 |
CN104082672A (zh) | 2014-10-08 |
CN104082672B (zh) | 2016-02-10 |
CN105166661A (zh) | 2015-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103690783B (zh) | 用于治疗糖尿病的中药制剂及其制备方法 | |
CN103656558A (zh) | 一种清心凉茶中药组合物及其制备方法 | |
CN104082672B (zh) | 一种具有降血糖功效的养生粥及其制作方法 | |
CN103602551B (zh) | 一种有助于消食健胃复方中草药发酵保健酒及其生产方法 | |
CN107412665B (zh) | 一种具有解酒、防治酒精性肝损伤的中药组合物及其制备方法和应用 | |
CN106075159A (zh) | 用于代谢综合症的保健茶饮及其制备方法 | |
CN105639009A (zh) | 一种养生保健铁皮石斛茶及其制备方法 | |
CN105394282A (zh) | 一种可降压降糖降脂的葛根保健茶 | |
CN115120684B (zh) | 一种治疗糖尿病的中药组方及其加工方法 | |
CN108815015A (zh) | 一种眼膜及其生产工艺 | |
CN107115515A (zh) | 一种降血糖保健中药组合物及其制备方法 | |
CN104984150A (zh) | 具有降血压功效养生粥的制备工艺 | |
CN105362674A (zh) | 一种用于治疗糖尿病的中药及其制备方法 | |
CN105995711A (zh) | 一种滇橄榄复方制剂及其制备方法 | |
CN104474342A (zh) | 一种适宜三高人群饮用的茶膏及其制备方法 | |
CN105106726A (zh) | 一种降低血液粘稠度养生粥的制备方法 | |
CN106387100A (zh) | 一种改善血液循环的米糠油及其制备方法 | |
CN105381225A (zh) | 一种用于治疗糖尿病的中药组合物及其制备方法 | |
CN105456704A (zh) | 一种用于治疗糖尿病的中药组合物 | |
CN105878796A (zh) | 一种治疗ⅱ型糖尿病合并血脂异常的醋饮及其制备方法 | |
CN104998174A (zh) | 一种防治脑萎缩的益智健脑制剂及制法 | |
CN104547541A (zh) | 一种补虚中药组合物及其制备方法 | |
CN104225185A (zh) | 一种降血糖口香糖及其生产方法 | |
CN113057317A (zh) | 一种适合糖尿病及其高危人群的分体质膏方 | |
CN109692277A (zh) | 一种治疗糖尿病的中草药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 550000 Guizhou, Nanming District, Castle Peak Road, No. 53 Qingshan District, building 1-101, No. 2, Applicant after: Zhu Luying Address before: 250014 Ji'nan Province, Lixia District, Lixia District, No. 24 East Road, home, building, No. 2, Applicant before: Zhu Luying |
|
COR | Change of bibliographic data | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20151216 |